Cargando…
Hepatocelluar Carcinoma Risk in Advanced Fibrosis After Sustained Virologic Response: When Can We Safely Stop Hepatocellular Carcinoma Surveillance?
Autores principales: | Enomoto, Masaru, Vutien, Philip, Kawada, Norifumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870040/ https://www.ncbi.nlm.nih.gov/pubmed/35202513 http://dx.doi.org/10.1002/hep4.1864 |
Ejemplares similares
-
Roles of Tumor Microenvironment in Hepatocelluar Carcinoma
por: Seo, Haeng R.
Publicado: (2015) -
Smad3 Sensitizes Hepatocelluar Carcinoma Cells to Cisplatin by Repressing Phosphorylation of AKT
por: Zhou, Hong-Hao, et al.
Publicado: (2016) -
Hepatic Artery Thrombosis: A Rare Complication of Microwave Ablation in Hepatocelluar Carcinoma
por: Aujla, Amreet K, et al.
Publicado: (2020) -
Combined effect of socioeconomic status, viral hepatitis, and lifestyles on hepatocelluar carcinoma risk in Korea
por: Yun, E H, et al.
Publicado: (2010) -
MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma
por: Huang, Jia-Yuan, et al.
Publicado: (2015)